Blood pressure improved
Patients can expect to see significant weight loss within the first three months of beginning Semaglutide GLP-1 treatment, although individual results may vary
A: The most common side effects of Semaglutide include nausea, diarrhea, vomiting, and constipation
Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual agonist for GLP-1 & GIP receptors
Either people really have to accept this as a treatment for life,, or we in science need to think really, really hard, how to support people when they stop the drug. While the study did not show causality, Jebb speculated that the difference in how fast people put weight back on could be due to the fact that diets are hard and people have to practise restraint to lose weight, whereas if you are taking a drug that knocks your hunger out completely, you dont have to make that effort